These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28069400)

  • 1. Rotational thromboelastometry in ex vivo samples from routine clinical practice patients receiving dabigatran.
    Božič-Mijovski M; Vene N; Snoj N; Gradišek P; Mavri A
    Clin Chim Acta; 2017 Mar; 466():20-21. PubMed ID: 28069400
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversal of dabigatran anticoagulation ex vivo: Porcine study comparing prothrombin complex concentrates and idarucizumab.
    Honickel M; Treutler S; van Ryn J; Tillmann S; Rossaint R; Grottke O
    Thromb Haemost; 2015 Apr; 113(4):728-40. PubMed ID: 25567155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole blood coagulation assays ROTEM and T-TAS to monitor dabigatran treatment.
    Taune V; Wallén H; Ågren A; Gryfelt G; Sjövik C; Wintler AM; Malmström RE; Wikman A; Skeppholm M
    Thromb Res; 2017 May; 153():76-82. PubMed ID: 28347811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid determination of anticoagulating effects of dabigatran in whole blood with rotational thromboelastometry and a thrombin-based trigger.
    Taune V; Skeppholm M; Ågren A; Gryfelt G; Malmström RE; Wikman A; Van Ryn J; Wallén H
    J Thromb Haemost; 2018 Dec; 16(12):2462-2470. PubMed ID: 30288934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of dabigatran and rivarovaban on a prothrombinase-based assay for activated protein C resistance: a preliminary study in subjects heterozygous for factor V Leiden.
    Gessoni G; Valverde S; Gessoni F; Valle R
    Blood Transfus; 2015 Oct; 13(4):666-8. PubMed ID: 25761318
    [No Abstract]   [Full Text] [Related]  

  • 6. From laboratory to clinical practice: Dabigatran effects on thrombin generation and coagulation in patient samples.
    Helin TA; Lemponen M; Hjemdahl P; Rönquist-Nii Y; Lassila R; Joutsi-Korhonen L
    Thromb Res; 2015 Jul; 136(1):154-60. PubMed ID: 25981140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of dabigatran on the kaolin-activated whole blood thromboelastogram.
    'Aho A; Byrne K
    Anaesth Intensive Care; 2016 Nov; 44(6):729-733. PubMed ID: 27832560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct Oral Anticoagulants (DOACs) in the Laboratory: 2015 Review.
    Adcock DM; Gosselin R
    Thromb Res; 2015 Jul; 136(1):7-12. PubMed ID: 25981138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of dabigatran on lupus anticoagulant, diluted plasma thrombin time, and other specialized coagulation assays.
    Kim YA; Gosselin R; Van Cott EM
    Int J Lab Hematol; 2015 Aug; 37(4):e81-4. PubMed ID: 25515302
    [No Abstract]   [Full Text] [Related]  

  • 10. Laboratory assessment of the anticoagulant activity of dabigatran.
    Kyriakou E; Ikonomidis I; Stylos D; Bonovas S; Papadakis I; Nikolopoulos GK; Kokoris S; Kalantzis D; Economopoulou C; Kopterides P; Lekakis J; Tsantes AE
    Clin Appl Thromb Hemost; 2015 Jul; 21(5):434-45. PubMed ID: 25525048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of dabigatran on pro-inflammatory cytokines, growth factors and chemokines - Slowing the vicious circle of coagulation and inflammation.
    Paar V; Jirak P; Gruber S; Prodinger C; Cadamuro J; Wernly B; Motloch LJ; Haschke-Becher E; Hoppe UC; Lichtenauer M
    Life Sci; 2020 Dec; 262():118474. PubMed ID: 32961229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ex vivo reversibility of dabigatran-induced whole-blood coagulopathy as monitored by thromboelastography: mechanistic implications for clinical medicine.
    Davis PK; Musunuru H; Walsh M; Mitra R; Ploplis V; Castellino FJ
    Thromb Haemost; 2012 Sep; 108(3):586-8. PubMed ID: 22782135
    [No Abstract]   [Full Text] [Related]  

  • 13. High-Dose Dabigatran Is an Effective Anticoagulant for Simulated Cardiopulmonary Bypass Using Human Blood.
    Nadtochiy SM; Baldzizhar A; Stefanos T; Feng C; O'Leary KE; Jones-Smith KL; Angona RE; Eaton MP
    Anesth Analg; 2021 Feb; 132(2):566-574. PubMed ID: 32833714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays.
    Lindahl TL; Baghaei F; Blixter IF; Gustafsson KM; Stigendal L; Sten-Linder M; Strandberg K; Hillarp A;
    Thromb Haemost; 2011 Feb; 105(2):371-8. PubMed ID: 21103660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Dabigatran Treatment on Rotation Thromboelastometry.
    Sokol J; Nehaj F; Ivankova J; Mokan M; Zolkova J; Lisa L; Linekova L; Mokan M; Stasko J
    Clin Appl Thromb Hemost; 2021; 27():1076029620983902. PubMed ID: 33523711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anticoagulant effect of dabigatran is reflected in the lag time and time-to-peak, but not in the endogenous thrombin potential or peak, of thrombin generation.
    Bloemen S; Zwaveling S; Douxfils J; Roest M; Kremers R; Mullier F
    Thromb Res; 2018 Nov; 171():160-166. PubMed ID: 30316961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthetic small-molecular thrombin inhibition as anticoagulants].
    Markwardt F; Vogel F
    Subsid Med; 1974; 4():57-61. PubMed ID: 4450562
    [No Abstract]   [Full Text] [Related]  

  • 18. Idarucizumab for dabigatran overdose in a child.
    Shapiro S; Bhatnagar N; Khan A; Beavis J; Keeling D
    Br J Haematol; 2018 Feb; 180(3):457-459. PubMed ID: 27734469
    [No Abstract]   [Full Text] [Related]  

  • 19. Determination of dabigatran in plasma, serum, and urine samples: comparison of six methods.
    Du S; Weiss C; Christina G; Krämer S; Wehling M; Krämer R; Harenberg J
    Clin Chem Lab Med; 2015 Jul; 53(8):1237-47. PubMed ID: 25720084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study.
    Glund S; Stangier J; van Ryn J; Schmohl M; Moschetti V; Haazen W; De Smet M; Gansser D; Norris S; Lang B; Reilly P; Kreuzer J
    Clin Pharmacokinet; 2017 Jan; 56(1):41-54. PubMed ID: 27317414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.